BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,130 filers reported holding BAXTER INTL INC in Q1 2022. The put-call ratio across all filers is 1.41 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,106,986 | -11.8% | 55,829 | +6.4% | 0.77% | -10.4% |
| Q2 2023 | $2,390,169 | +10.8% | 52,462 | -1.4% | 0.86% | +13.7% |
| Q1 2023 | $2,157,589 | -16.5% | 53,195 | +4.9% | 0.76% | -14.6% |
| Q4 2022 | $2,583,924 | -5.6% | 50,695 | -0.2% | 0.89% | -16.7% |
| Q3 2022 | $2,737,000 | -13.8% | 50,820 | +2.8% | 1.07% | -6.3% |
| Q2 2022 | $3,174,000 | -17.2% | 49,420 | 0.0% | 1.14% | -8.7% |
| Q1 2022 | $3,832,000 | -13.3% | 49,420 | -4.1% | 1.25% | -9.6% |
| Q4 2021 | $4,422,000 | +6.7% | 51,520 | 0.0% | 1.38% | +0.6% |
| Q3 2021 | $4,144,000 | -0.1% | 51,520 | 0.0% | 1.37% | +2.4% |
| Q2 2021 | $4,147,000 | -4.6% | 51,520 | 0.0% | 1.34% | -8.5% |
| Q1 2021 | $4,345,000 | +5.1% | 51,520 | 0.0% | 1.46% | -4.9% |
| Q4 2020 | $4,134,000 | -0.2% | 51,520 | 0.0% | 1.54% | -9.3% |
| Q3 2020 | $4,143,000 | -7.8% | 51,520 | -1.3% | 1.70% | -10.0% |
| Q2 2020 | $4,493,000 | +6.0% | 52,187 | 0.0% | 1.88% | -5.8% |
| Q1 2020 | $4,237,000 | -2.9% | 52,187 | 0.0% | 2.00% | +29.2% |
| Q4 2019 | $4,364,000 | -4.4% | 52,187 | 0.0% | 1.55% | -10.2% |
| Q3 2019 | $4,565,000 | +6.8% | 52,187 | 0.0% | 1.72% | +6.4% |
| Q2 2019 | $4,274,000 | +0.7% | 52,187 | 0.0% | 1.62% | -0.6% |
| Q1 2019 | $4,243,000 | +23.5% | 52,187 | 0.0% | 1.63% | +12.1% |
| Q4 2018 | $3,435,000 | -16.2% | 52,187 | -1.9% | 1.46% | -5.2% |
| Q3 2018 | $4,100,000 | +4.4% | 53,187 | 0.0% | 1.54% | -1.4% |
| Q2 2018 | $3,927,000 | +12.7% | 53,187 | -0.7% | 1.56% | +12.7% |
| Q1 2018 | $3,485,000 | -3.2% | 53,587 | -3.8% | 1.38% | +2.4% |
| Q4 2017 | $3,600,000 | +3.0% | 55,687 | 0.0% | 1.35% | -1.6% |
| Q3 2017 | $3,494,000 | +3.6% | 55,687 | 0.0% | 1.37% | +0.1% |
| Q2 2017 | $3,371,000 | +15.0% | 55,687 | -1.5% | 1.37% | +14.4% |
| Q1 2017 | $2,932,000 | +18.0% | 56,537 | +0.9% | 1.20% | +13.4% |
| Q4 2016 | $2,485,000 | -9.3% | 56,037 | -2.6% | 1.06% | -11.1% |
| Q3 2016 | $2,740,000 | +2.9% | 57,554 | -2.3% | 1.19% | +5.0% |
| Q2 2016 | $2,664,000 | +10.1% | 58,904 | 0.0% | 1.13% | +2.8% |
| Q1 2016 | $2,420,000 | +7.7% | 58,904 | 0.0% | 1.10% | +6.3% |
| Q4 2015 | $2,247,000 | +14.9% | 58,904 | -1.0% | 1.04% | +8.3% |
| Q3 2015 | $1,956,000 | -53.0% | 59,529 | 0.0% | 0.96% | -49.8% |
| Q2 2015 | $4,163,000 | +51.7% | 59,529 | +48.5% | 1.90% | +55.0% |
| Q1 2015 | $2,745,000 | -7.5% | 40,079 | -1.0% | 1.23% | -5.7% |
| Q4 2014 | $2,967,000 | +13.1% | 40,479 | +10.7% | 1.30% | +7.8% |
| Q3 2014 | $2,623,000 | -2.2% | 36,554 | -1.4% | 1.21% | -3.4% |
| Q2 2014 | $2,681,000 | -1.7% | 37,079 | 0.0% | 1.25% | -6.6% |
| Q1 2014 | $2,728,000 | +5.8% | 37,079 | 0.0% | 1.34% | +3.2% |
| Q4 2013 | $2,579,000 | +5.6% | 37,079 | -0.3% | 1.30% | -3.1% |
| Q3 2013 | $2,442,000 | -5.4% | 37,179 | -0.3% | 1.34% | -9.5% |
| Q2 2013 | $2,582,000 | – | 37,279 | – | 1.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |